| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/16/2006 | US20060058256 Capable of inducing breakdown of mrna enzymes that break down connective tissue; particularly suited for treating degenerative skin disorders; pharmaceutical and cosmetic compositions for topical application and which contain the oligoribonucleotides |
| 03/16/2006 | US20060058255 RNAi-based therapeutics for allergic rhinitis and asthma |
| 03/16/2006 | US20060058254 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 03/16/2006 | US20060058253 Methods to reprogram splice site selection in pre-messenger rnas |
| 03/16/2006 | US20060058252 Methods and materials for treating human papillomavirus infections |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060058249 Efficient nucleic acid encapsulation into medium sized liposomes |
| 03/16/2006 | US20060058239 Use of the insulin-like-growth factor I isoform MGF for the treatment of neurological disorders |
| 03/16/2006 | US20060058225 Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease |
| 03/16/2006 | US20060058223 TAJ in neuronal function |
| 03/16/2006 | US20060057725 Therapeutic retroviral vectors for gene therapy |
| 03/16/2006 | US20060057714 Vector |
| 03/16/2006 | US20060057574 Tissue specific expression |
| 03/16/2006 | US20060057570 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 03/16/2006 | US20060057553 Chimeric viral vectors for gene therapy |
| 03/16/2006 | US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
| 03/16/2006 | US20060057163 adjuvant compound chosen from the acrylic or methacrylic polymers and the copolymers of maleic anhydride and an alkenyl derivative especially with polyalkenyl ethers of sugars or polyalcohols; heterologus influenza protein |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |
| 03/16/2006 | US20060057154 Compositions for inducing of immunotolerance |
| 03/16/2006 | US20060057153 Method and composition for the inhibition of mitosis |
| 03/16/2006 | US20060057147 Antibody recognizing antibody |
| 03/16/2006 | US20060057143 Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11) |
| 03/16/2006 | US20060057130 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides |
| 03/16/2006 | US20060057129 Preloaded dendritic cell vaccines for treating cancer |
| 03/16/2006 | US20060057128 Intradiscal injection of autologous interferon |
| 03/16/2006 | US20060057127 Cytokine-expressing cellular vaccines for treatment of prostate cancer |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | US20060057116 Recombinant influenza viruses for vaccines and gene therapy |
| 03/16/2006 | US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 03/16/2006 | US20060057114 Preventing/inhibiting metabolic disorders characterized by absence or reduced levels of alpha-L-iduronidase in newborn mammals by administering recombinant lentivirus comprising nucleic acid segment encoding alpha-L-iduronidase |
| 03/16/2006 | US20060057113 Novel adenoviruses, nucleic acids coding therefor, and use thereof |
| 03/16/2006 | US20060057109 Method of using anti-apoptotic factors in gene expression |
| 03/16/2006 | US20060057105 Methods of treating ocular inflammation and allergy |
| 03/16/2006 | US20060057104 Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses |
| 03/16/2006 | US20060057072 Method for diagnosis and treatment of vascular disease |
| 03/16/2006 | DE102004042822A1 Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen Compounds and methods for the treatment, diagnosis and prognosis in pancreatic diseases |
| 03/16/2006 | DE102004037611A1 Induzierbare Genexpression Inducible gene expression |
| 03/16/2006 | CA2583375A1 Regulation of oncogenes by micrornas |
| 03/15/2006 | EP1634956A1 Recombinant adeno-associated virus vector for treatment of alzheimer disease |
| 03/15/2006 | EP1634955A1 Conditional gene vectors regulated in cis |
| 03/15/2006 | EP1634892A2 Composition and methods for the diagnosis of tumours |
| 03/15/2006 | EP1633890A2 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi |
| 03/15/2006 | EP1633872A2 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/15/2006 | EP1633871A1 Double-stranded nucleic acid |
| 03/15/2006 | EP1633860A2 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 03/15/2006 | EP1633858A2 Room temperature storage of organs |
| 03/15/2006 | EP1633769A1 Novel transcription factor, bp1 |
| 03/15/2006 | EP1633767A2 Methods and compositions for controlling efficacy of rna silencing |
| 03/15/2006 | EP1633387A2 Combinations of tumor-associated antigens for the treatment of various types of cancers |
| 03/15/2006 | EP1633386A1 Pharmaceutical composition for inducing apoptosis comprising a fusion protein between bfl-1 and green fluorescent protein or a gene encoding same |
| 03/15/2006 | EP1633327A1 Method for improving stability and shelf-life of liposome complexes |
| 03/15/2006 | EP1633307A2 Modulation of survivin expression |
| 03/15/2006 | EP1294893B1 Modification of hepatitis b core antigen |
| 03/15/2006 | EP1294864B1 Mutated furin polypeptides having improved characteristics |
| 03/15/2006 | EP1246905B1 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 03/15/2006 | EP0966685B9 Protein fragment complementation assays to detect biomolecular interactions |
| 03/15/2006 | EP0939590B1 Nucleic acids for use in gene therapy involving intestinal cell gene expression |
| 03/15/2006 | EP0892849B1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 03/15/2006 | EP0870049B1 Complementary adenoviral vector systems and cell lines |
| 03/15/2006 | EP0797436B1 Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| 03/15/2006 | CN1748034A Improved genetic elements providing high levels of expression |
| 03/15/2006 | CN1747744A Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 03/15/2006 | CN1746297A Placenta source filling dry cell and production thereof |
| 03/15/2006 | CN1746184A Trichosanthin mutant and coding gene thereof |
| 03/15/2006 | CN1245508C Human atrial natriuretic peptide gene, its strong mutant and its application in treating relative diseases |
| 03/15/2006 | CN1245419C Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 03/14/2006 | US7013219 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 03/14/2006 | US7012134 Dendritic enriched secreted lymphocyte activation molecule |
| 03/14/2006 | US7011976 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 03/14/2006 | US7011973 recombinant DNA molecules comprising regulatory sequences of an intron of the Vascular Endothelial Growth Factor receptor-2 gene or of a gene homologous to the Flk-1 gene, being capable of conferring expression of a heterologous DNA sequence |
| 03/14/2006 | US7011968 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 03/14/2006 | US7011831 Recombinant α-galactosidase A therapy for Fabry disease |
| 03/14/2006 | US7011828 Regeneration cells of nervous system |
| 03/14/2006 | US7011827 Compositions and methods for producing and using homogenous neuronal cell transplants |
| 03/14/2006 | CA2154854C Immortalized lymphocytes for production of viral-free proteins |
| 03/09/2006 | WO2006026570A2 Use of stem cells to generate inner ear cells |
| 03/09/2006 | WO2006026524A2 Werner's syndrome helicase as a target for anti-hiv/aids therapy |
| 03/09/2006 | WO2006026485A2 Modulation of hif1-beta expression |
| 03/09/2006 | WO2006026451A2 Targeted expression of apoptosis-inducing genes for disease treatment |
| 03/09/2006 | WO2006026331A2 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells |
| 03/09/2006 | WO2006025808A2 Cross reactive arrays of three-way junction sensors for steroid determination |
| 03/09/2006 | WO2006025425A1 Protein participating in inhibition of plasmodium growth |
| 03/09/2006 | WO2006024694A2 Peptide inhibitors of hk2 and their use |
| 03/09/2006 | WO2006024122A1 Immunogenic compositions |
| 03/09/2006 | WO2006002627A9 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 03/09/2006 | WO2005117992A3 Controlled delivery of therapeutic compounds |
| 03/09/2006 | WO2005115358A3 Intranasal delivery of nucleic acid molecules |
| 03/09/2006 | WO2005072347A3 Inositol 1,4,5- trisphosphate receptor mutants and uses thereof |
| 03/09/2006 | WO2005055925A3 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 03/09/2006 | WO2005044993A3 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 03/09/2006 | WO2004069326A3 Light probe for ultraviolet light activated gene transduction |
| 03/09/2006 | WO2004028471A3 Influenza therapeutic |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 03/09/2006 | US20060052592 Vaccines for suppressing ige-mediated allergic disease and methods for using the same |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052585 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 03/09/2006 | US20060052433 Compound |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052328 Connective tissue growth factor-2 |